Biotech CEO Sisterhood

Interviewed by Sisterhood Editorial Board Member Erika Smith, Paul Soteropoulos describes her experiences working for companies across a variety of modalities. Plus, she highlights the new women's health book she and her daughter co-authored: Restoring Balance.

Interviewed by Sisterhood Editorial Board Member Erika Smith, Rachel King reflects on her time at NEA and 18 years as the Co-Founder & CEO at GlycoMimetics, as well as stepping into the role of BIO's CEO on an interim basis. She offers leadership advice, and describes the ways she still says active in biotech today.

She describes how the mission of getting the company on stable ground through financial discipline and a sharper focus on strategy has enabled it to thrive and deliver on its mission for patients. Plus, her advice to others having gone through it as a first time CEO.

Interviewed by Sisterhood editorial board member Erika Smith, Amy Burroughs discusses joining Terns when it was not obvious and at a time when the company was going through a sad moment, and how the momentum started to turn as data for TERN-701 started becoming apparent. She describes her career, which included stops at large and small companies, and on the investing side at 5AM Ventures, and provides leadership lessons along the way.

Interviewed by Sisterhood editorial board member Erika Smith, Lyn Baranowski highlights the company's $345 million IPO, which enables it to further develop its inhaled medicines. She describes why they believe this delivery method provides a more direct and efficient way to treat fibrotic lung conditions like IPF.

They describe the Sisterhood's modest beginnings, its impact already, and plans for the future. It now has a 501c3 charity structure and more formal leadership, and there are new efforts to reach other c-suite level women in biotech.

Interviewed by Sisterhood editorial board member Daphne Zohar, Kate Haviland talks about the numerous programs that Blueprint created, the rationale behind key go/no-go and partnering decisions, and how she feels about the biotech sector today.

Interviewed by Sisterhood editorial board member Erika Smith, Nina Tandon describes what it has taken to get a startup through the recent difficult times for the biotech sector, including applying for military funding and making the product available in international markets where compassionate use is an option.

Interviewed by Sisterhood editorial board member Grace Colón, Dr. Gujrathi discusses a three pillar framework for success she has learned during her career in life sciences: know thyself, understand your environment, and set yourself up for success.

Interviewed by Sisterhood editorial board member Erika Smith, Reenie McCarthy discusses how working with the Barth Syndrome Community, an ultra rare disease, helped the company better understand outcomes that are important to daily life for these patients. She also highlights the role that mitochondria play in biology, and the future of treatments for diseases of mitochondrial dysfunction.